• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of virucidal heat treatment on proteins in human factor VIII concentrates.

作者信息

Thomas K B, McGrath K M, Taylor M, Young I F, Herrington R W, Schiff P

机构信息

Red Cross Blood Bank, South Melbourne, Australia.

出版信息

Transfusion. 1988 Jan-Feb;28(1):8-13. doi: 10.1046/j.1537-2995.1988.28188127962.x.

DOI:10.1046/j.1537-2995.1988.28188127962.x
PMID:3124306
Abstract

Intermediate-purity and fibrinogen-poor factor VIII concentrates were heated in the lyophilized state at 60 degrees C for up to 72 hours to inactivate blood-borne viruses. The effect of heat treatment on factor VIII, von Willebrand factor (vWf), and other proteins present in the concentrates (albumin, fibrinogen, fibronectin, IgG, and IgM) was evaluated. Heat-induced protein aggregation, particularly of fibrinogen and fibronectin, occurred within 48 hours in the intermediate-purity concentrates and correlated well with decreased solubility of these products. Heated fibrinogen-poor concentrates were readily soluble and did not show protein aggregation even after 72 hours at 60 degrees C. Neither concentrate developed detectable neoantigens when tested against antisera to whole human plasma and to heated and unheated concentrates. Aggregation of the vWf molecule, detected by altered mobility in crossed immunoelectrophoresis and multimeric analysis in SDS agarose gels, occurred in heated intermediate-purity concentrates but not in fibrinogen-poor concentrates. Thus, higher-purity factor VIII concentrates withstand heat treatment better than concentrates that contain greater levels of contaminating proteins, particularly fibrinogen.

摘要

相似文献

1
Effect of virucidal heat treatment on proteins in human factor VIII concentrates.
Transfusion. 1988 Jan-Feb;28(1):8-13. doi: 10.1046/j.1537-2995.1988.28188127962.x.
2
Characteristics of the von Willebrand factor in virus inactivated F VIII concentrates: the impact of heat treatment.病毒灭活的凝血因子 VIII 浓缩物中血管性血友病因子的特性:热处理的影响
Thromb Res. 1987 Jul 15;47(2):175-82. doi: 10.1016/0049-3848(87)90374-4.
3
[Study of a therapeutic concentrate of factor VIII/vWf prepared in a closed system].
Rev Fr Transfus Immunohematol. 1982 Feb;25(1):25-43. doi: 10.1016/s0338-4535(82)80078-0.
4
In vitro characterization of various factor VIII concentrates.多种凝血因子VIII浓缩物的体外特性研究
Arzneimittelforschung. 1987 Jul;37(7):753-6.
5
Cryoprecipitate and Factor VIII commercial concentrates: in vitro characteristics and in vivo compartmental analysis.
Ric Clin Lab. 1984 Oct-Dec;14(4):681-91. doi: 10.1007/BF02906309.
6
Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates.血浆源性凝血因子 VIII-血管性血友病因子浓缩物的蛋白质组学特征。
Electrophoresis. 2009 Oct;30(20):3636-46. doi: 10.1002/elps.200900270.
7
Multimers of von Willebrand antigen in therapeutic factor VIII concentrates.治疗性凝血因子VIII浓缩物中血管性血友病因子抗原多聚体
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(6):831-40.
8
Use of heat-treated clotting-factor concentrates in patients with haemophilia and a high exposure to HTLV-III.
Med J Aust. 1985 Jul 8;143(1):11-3. doi: 10.5694/j.1326-5377.1985.tb122758.x.
9
Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.病毒灭活血浆和F VIII浓缩物中的血管性血友病因子多聚体。
Beitr Infusionsther Transfusionsmed. 1994;32:408-14.
10
Influence of dry heat treatment and anticoagulant on coupling of fibrinogen and fibronectin to von Willebrand factor in normal plasma.干热处理和抗凝剂对正常血浆中纤维蛋白原和纤连蛋白与血管性血友病因子结合的影响。
Scand J Clin Lab Invest. 1992 Nov;52(7):731-9. doi: 10.3109/00365519209115519.